Cargando…
Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion
Among high-grade brain tumors, glioblastoma is particularly difficult to treat, in part due to its highly infiltrative nature which contributes to the malignant phenotype and high mortality in patients. In order to better understand the signaling pathways underlying glioblastoma invasion, we perform...
Autores principales: | Prolo, Laura M., Li, Amy, Owen, Scott F., Parker, Jonathon J., Foshay, Kara, Nitta, Ryan T., Morgens, David W., Bolin, Sara, Wilson, Christy M., Vega L, Johana C. M., Luo, Emily J., Nwagbo, Gigi, Waziri, Allen, Li, Gordon, Reimer, Richard J., Bassik, Michael C., Grant, Gerald A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768851/ https://www.ncbi.nlm.nih.gov/pubmed/31570734 http://dx.doi.org/10.1038/s41598-019-50160-w |
Ejemplares similares
-
Systematic comparison of CRISPR-Cas9 and RNAi screens for essential genes
por: Morgens, David W, et al.
Publicado: (2016) -
Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
por: Parker, Jonathon J., et al.
Publicado: (2018) -
Immunogenetics of glioblastoma: the future of personalized patient management
por: Abedalthagafi, Malak, et al.
Publicado: (2018) -
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
por: Deans, Richard M., et al.
Publicado: (2016) -
Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions
por: Han, Kyuho, et al.
Publicado: (2017)